Healthy individuals have low levels of NF-L in the blood, whereas high levels of NF-L are detected in degenerative diseases, including Amyotrophic lateral sclerosis (ALS), MS, and Alzheimer’s disease (AD) [52,53,54]. This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.